Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1981 2
1982 1
1983 3
1985 1
1987 1
1989 1
1990 1
1991 1
1992 4
1993 1
1994 2
1995 4
1996 3
1997 4
1998 7
1999 12
2000 13
2001 14
2002 12
2003 20
2004 25
2005 24
2006 34
2007 54
2008 34
2009 56
2010 52
2011 64
2012 52
2013 54
2014 60
2015 58
2016 54
2017 52
2018 54
2019 44
2020 47
2021 58
2022 57
2023 49
2024 47
2025 63
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,066 results

Results by year

Filters applied: . Clear all
Page 1
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study.
Tabernero J, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, Desai J, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Elez E, Gollerkeri A, Maharry K, Christy-Bittel J, Kopetz S. Tabernero J, et al. Among authors: hong ys. J Clin Oncol. 2021 Feb 1;39(4):273-284. doi: 10.1200/JCO.20.02088. J Clin Oncol. 2021. PMID: 33503393 Free PMC article. Clinical Trial.
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, Wasan H, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Pfeiffer P, Orlov S, Lonardi S, Elez E, Kim TW, Schellens JHM, Guo C, Krishnan A, Dekervel J, Morris V, Calvo Ferrandiz A, Tarpgaard LS, Braun M, Gollerkeri A, Keir C, Maharry K, Pickard M, Christy-Bittel J, Anderson L, Sandor V, Tabernero J. Kopetz S, et al. Among authors: hong ys. N Engl J Med. 2019 Oct 24;381(17):1632-1643. doi: 10.1056/NEJMoa1908075. Epub 2019 Sep 30. N Engl J Med. 2019. PMID: 31566309 Clinical Trial.
Reversible compromise of physiological resilience by accumulation of heteroplasmic mtDNA mutations.
Huang H, Wang Y, Zsengeller ZK, Gorham JM, Vemireddy V, Clark AJ, Pan H, Dreyfuss JM, Jotwani V, Shlipak MG, Sarnak MJ, Parikh CR, Thiessen-Philbrook H, Katz R, Waikar SS, Lake NJ, Lek M, Shi W, Puiu D, Hong YS, Seidman JG, Arking DE, Parikh SM. Huang H, et al. Among authors: hong ys. Science. 2025 Oct 9;390(6769):164-172. doi: 10.1126/science.adk7978. Epub 2025 Sep 4. Science. 2025. PMID: 40906782
Rare Cause of Exertional Angina.
Seo KW, Hong YS, Park JS. Seo KW, et al. Among authors: hong ys. J Korean Med Sci. 2023 Dec 25;38(50):e421. doi: 10.3346/jkms.2023.38.e421. J Korean Med Sci. 2023. PMID: 38147842 Free PMC article. No abstract available.
Evaluation and management of lead exposure.
Kim HC, Jang TW, Chae HJ, Choi WJ, Ha MN, Ye BJ, Kim BG, Jeon MJ, Kim SY, Hong YS. Kim HC, et al. Among authors: hong ys. Ann Occup Environ Med. 2015 Dec 15;27:30. doi: 10.1186/s40557-015-0085-9. eCollection 2015. Ann Occup Environ Med. 2015. PMID: 26677413 Free PMC article. Review.
Nigral MRI features of asymptomatic welders.
Lee EY, Flynn MR, Du G, Lewis MM, Goldenberg M, Kong L, Mailman RB, Hong YS, Huang X. Lee EY, et al. Among authors: hong ys. Parkinsonism Relat Disord. 2021 Apr;85:37-43. doi: 10.1016/j.parkreldis.2021.02.020. Epub 2021 Feb 24. Parkinsonism Relat Disord. 2021. PMID: 33691274 Free PMC article.
Mitochondrial DNA copy number variation in asthma risk, severity, and exacerbations.
Xu W, Hong YS, Hu B, Comhair SAA, Janocha AJ, Zein JG, Chen R, Meyers DA, Mauger DT, Ortega VE, Bleecker ER, Castro M, Denlinger LC, Fahy JV, Israel E, Levy BD, Jarjour NN, Moore WC, Wenzel SE, Gaston B, Liu C, Arking DE, Erzurum SC; National Heart, Lung, and Blood Institute (NHLBI) Severe Asthma Research Program and TOPMed mtDNA Working Group in NHLBI Trans-omics for Precision Medicine (TOPMed) Consortium. Xu W, et al. Among authors: hong ys. J Allergy Clin Immunol. 2025 Apr;155(4):1224-1235. doi: 10.1016/j.jaci.2024.08.022. Epub 2024 Sep 3. J Allergy Clin Immunol. 2025. PMID: 39237012
1,066 results